BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. May 7, 2026; 32(17): 117479
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.117479
Table 3 Comparison of baseline characteristics between patients with and without pathological samples, mean ± SD/n (%)

Sampled group (n = 102)
Non-sampled group (n = 69)
t/χ2 value
P value
Age (years)47.0 ± 4.446.9 ± 5.00.1160.908
Gender0.4710.493
Male72 (70.6)52 (75.4)
Female30 (29.4)17 (24.6)
Background disease2.0130.959
HBV cirrhosis46 (45.1)34 (49.3)
HCV cirrhosis2 (2.0)0 (0.0)
ALC22 (21.5)13 (18.8)
PBC4 (3.9)3 (4.4)
AIC6 (5.9)4 (5.8)
BCS7 (6.9)5 (7.2)
HVOD3 (2.9)3 (4.4)
Unknown cause12 (11.8)7 (10.1)
Clinical symptoms7.1790.208
Abdominal pain20 (19.6)6 (8.7)
Variceal bleeding30 (29.4)26 (37.7)
Refractory ascites25 (24.5)20 (29.0)
Both above19 (18.7)14 (20.3)
Intestinal necrosis4 (3.9)0 (0.0)
Severe jaundice4 (3.9)3 (4.3)
Child-Pugh grade0.0590.971
Grade A38 (37.3)26 (37.7)
Grade B46 (45.1)30 (43.5)
Grade C18 (17.6)13 (18.8)
PVT classification0.7890.852
Acute PVT27 (26.5)19 (27.5)
Chronic PVT34 (33.3)25 (36.2)
Cavernous transformation15 (14.7)7 (10.2)
Mixed PVT26 (25.5)18 (26.1)


Write to the Help Desk